We first examined CP activity in supporting leukocyte trafficking to the CNS along disease progression in the 5XFAD transgenic mouse model of AD (AD-Tg); these mice co-express five mutations associated with familial AD, and develop cerebral Aβ pathology and gliosis as early as 2 months of age24. This evidence concerns the gene CP and Alzheimer disease.